Acute caffeine supplementation improves jumping, sprinting, and change-of-direction performance in basketball players when ingested in the morning but not evening

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14510%2F22%3A00124922" target="_blank" >RIV/00216224:14510/22:00124922 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.tandfonline.com/doi/full/10.1080/17461391.2021.1874059" target="_blank" >https://www.tandfonline.com/doi/full/10.1080/17461391.2021.1874059</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1080/17461391.2021.1874059" target="_blank" >10.1080/17461391.2021.1874059</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Acute caffeine supplementation improves jumping, sprinting, and change-of-direction performance in basketball players when ingested in the morning but not evening

Popis výsledku v původním jazyce

This study compared the effects of acute caffeine supplementation (3 mg/kg) administered in the morning and evening on performance-related variables in basketball players. Eleven, national-level, adolescent male basketball players underwent field-based fitness testing on four occasions: morning (10:00) with caffeine ingestion (AMCAFF), morning (10:00) with placebo ingestion (AMPLAC), evening (21:00) with caffeine ingestion (PMCAFF), and evening (21:00) with placebo ingestion (PMPLAC). Fitness testing included of a countermovement jump without arm swing (CMJ), CMJ with arm swing (CMJAS), squat jump (SJ), Lane Agility Drill (LAD), 20-m linear sprint, and Suicide Run with (SRD) and without dribbling (SR). Data were analysed using two-way repeated measures analyses of variance and paired t-tests, with effect sizes (ES) also determined for all pairwise comparisons. Follow-up t-test comparisons revealed that AMCAFF produced small-moderate, significant (p&lt;0.001), improvements in CMJ (ES = 0.51), CMJAS (ES = 0.40), SJ (ES = 0.51), and SR (ES = −0.45) compared to AMPLAC. AMCAFF also produced a moderate, significantly (p&lt;0.001) faster LAD (ES = −0.61) compared to PMCAFF. PMPLAC demonstrated small-moderate, significant (p&lt;0.05) improvements in CMJ (ES = 0.43), CMJAS (ES = 0.48), and 20-m sprint (ES = −0.63) compared to AMPLAC. In contrast, AMPLAC resulted in large, significantly (p&lt;0.001), faster SRD (ES = −1.46) and SR (ES = −1.59) compared to PMPLAC. Given the ergogenic effects of caffeine during basketball-specific fitness tests appear to be influenced by time of ingestion, basketball practitioners should consider administering caffeine only to players in the morning to improve vertical jump, sprinting, and change-of-direction performance, with no beneficial effects observed with caffeine ingestion in the evening.

Název v anglickém jazyce

Acute caffeine supplementation improves jumping, sprinting, and change-of-direction performance in basketball players when ingested in the morning but not evening

Popis výsledku anglicky

This study compared the effects of acute caffeine supplementation (3 mg/kg) administered in the morning and evening on performance-related variables in basketball players. Eleven, national-level, adolescent male basketball players underwent field-based fitness testing on four occasions: morning (10:00) with caffeine ingestion (AMCAFF), morning (10:00) with placebo ingestion (AMPLAC), evening (21:00) with caffeine ingestion (PMCAFF), and evening (21:00) with placebo ingestion (PMPLAC). Fitness testing included of a countermovement jump without arm swing (CMJ), CMJ with arm swing (CMJAS), squat jump (SJ), Lane Agility Drill (LAD), 20-m linear sprint, and Suicide Run with (SRD) and without dribbling (SR). Data were analysed using two-way repeated measures analyses of variance and paired t-tests, with effect sizes (ES) also determined for all pairwise comparisons. Follow-up t-test comparisons revealed that AMCAFF produced small-moderate, significant (p&lt;0.001), improvements in CMJ (ES = 0.51), CMJAS (ES = 0.40), SJ (ES = 0.51), and SR (ES = −0.45) compared to AMPLAC. AMCAFF also produced a moderate, significantly (p&lt;0.001) faster LAD (ES = −0.61) compared to PMCAFF. PMPLAC demonstrated small-moderate, significant (p&lt;0.05) improvements in CMJ (ES = 0.43), CMJAS (ES = 0.48), and 20-m sprint (ES = −0.63) compared to AMPLAC. In contrast, AMPLAC resulted in large, significantly (p&lt;0.001), faster SRD (ES = −1.46) and SR (ES = −1.59) compared to PMPLAC. Given the ergogenic effects of caffeine during basketball-specific fitness tests appear to be influenced by time of ingestion, basketball practitioners should consider administering caffeine only to players in the morning to improve vertical jump, sprinting, and change-of-direction performance, with no beneficial effects observed with caffeine ingestion in the evening.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30306 - Sport and fitness sciences

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European Journal of Sport Science

ISSN

1746-1391

e-ISSN

1536-7290

Svazek periodika

22

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

11

Strana od-do

360-370

Kód UT WoS článku

000614178100001

EID výsledku v databázi Scopus

2-s2.0-85100328816